JP MORGAN/CALL/VERTEX PHARMACEUTICALS/455/0.1/17.01.25 Share Price

Warrant

DE000JB95Z96

Market Closed - Börse Stuttgart 09:46:42 01/07/2024 BST
5.25 EUR -4.55% Intraday chart for JP MORGAN/CALL/VERTEX PHARMACEUTICALS/455/0.1/17.01.25
Current month-4.55%
1 month+24.70%
Date Price Change
01/07/24 5.25 -4.55%
28/06/24 5.5 -1.79%
27/06/24 5.6 -1.58%
25/06/24 5.69 +5.37%
24/06/24 5.4 -3.91%

Delayed Quote Börse Stuttgart

Last update July 01, 2024 at 09:46 am

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying VERTEX PHARMACEUTICALS INCORPORATED
Issuer J.P. Morgan
WKN JB95Z9
ISINDE000JB95Z96
Date issued 21/12/2023
Strike 455 $
Maturity 17/01/2025 (200 Days)
Parity 10 : 1
Emission price 3.22
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 6.64
Lowest since issue 2.36
Spread 0.2
Spread %3.62%

Company Profile

Vertex Pharmaceuticals Incorporated specializes in the research, development and marketing of micromolecular drugs primarily for the treatment of cancers, viral, inflammatory and auto-immune diseases. Net sales are distributed geographically as follows: the United States (61.2%), Europe (31.5%) and other (7.3%).
Sector
-
More about the company

Ratings for Vertex Pharmaceuticals Incorporated

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: Vertex Pharmaceuticals Incorporated

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
32
Last Close Price
471.2 USD
Average target price
468.3 USD
Spread / Average Target
-0.63%
Consensus